By analyzing the LSPN and considering the mechanisms associated with MG, we identified the potentially significant roles of the MAPK signaling pathway (hsa04010), six high-risk genes (BCL2, KRAS, MAPK14, VEGFA, RAF1, and ESR1), and associated lncRNA-SNPs in MG. The gene discussed is VEGFA; the disease is myasthenia gravis.